The DOI matches its Crossref record.
Hydrogen Sulfide and Cancer
Abstract
Recent studies revealed increased expression of various hydrogen sulfide (H2S) producing enzymes in cancer cells of various tissue types, and new roles of H2S in the pathophysiology of cancer have emerged. This is particularly evident in cancers of the colon and ovaries, where the malignant cells both overexpress cystathionine-β-synthase (CBS) and produce increased amounts of H2S, which enhances tumor growth and spread by (a) stimulating cellular bioenergetics, (b) activating proliferative, migratory, and invasive signaling pathways, and (c) enhancing tumor angiogenesis. Importantly, in preclinical models of these cancers, either pharmacological inhibition or genetic silencing of CBS was shown to be sufficient to suppress cancer cell bioenergetics in vitro, inhibit tumor growth and metastasis in vivo, and enhance the antitumor efficacy of front-line chemotherapeutic agents, providing a strong rationale for the development of CBS-targeted inhibitors as anticancer therapies. However, the observation that inhibition of H2S biosynthesis exerts anticancer effects is contradicted by other studies showing that increasing H2S with exogenous donors also exert antitumor actions. Herein, we present a brief review of the scientific literature documenting the function of H2S, H2S donors, and transsulfuration enzymes in cancers from various tissue types, and propose that the paradoxical actions of H2S can be resolved by considering the bell-shaped pharmacology of H2S, whereby lower (endogenous) H2S production tend to promote, while higher (generated from exogenously added H2S donors) tend to inhibit cancer cell proliferation. Finally, we suggest areas for future investigations to expand our knowledge of this nascent field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Chemical Biology of H2S Signaling through Persulfidation
Filipovic, M. R., Zivanovic, J., Alvarez, B., & Banerjee, R. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00205 · Cited by 1,046
Cao, X., Ding, L., Xie, Z.-Z., Yang, Y., Whiteman, M., Moore, P. K., & Bian, J.-S. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7058 · Cited by 408
Role of Oral Microbiota in Cancer Development
Karpiński, T. M. (2019) · Microorganisms · doi:10.3390/microorganisms7010020 · Cited by 366
Hydrogen sulfide signaling in mitochondria and disease
Murphy, B., Bhattacharya, R., & Mukherjee, P. (2019) · The FASEB Journal · doi:10.1096/fj.201901304r · Cited by 279
Cysteine metabolic circuitries: druggable targets in cancer
Bonifácio, V. D. B., Pereira, S. A., Serpa, J., & Vicente, J. B. (2021) · British Journal of Cancer · doi:10.1038/s41416-020-01156-1 · Cited by 264
Metadata
- Authors
- Hellmich, M. R., & Szabo, C.
- Venue
- Handbook of Experimental Pharmacology
- Publisher
- Springer International Publishing
- Published
- 2015
- Volume
- 230
- Pages
- 233-241
- ISSN
- 0171-2004 (ISSN-L)
- 1865-0325
- OpenAlex
- W1787354014
- Cited by
- 239
- References
- 0
- FWCI
- 18.99
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hydrogen Sulfide and Cancer. https://app.cochat.ai/papers/10.1007/978-3-319-18144-8_12
- The paper
- Hellmich, M. R., & Szabo, C. (2015). Hydrogen Sulfide and Cancer. Handbook of Experimental Pharmacology. https://doi.org/10.1007/978-3-319-18144-8_12
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.